Mouse Anti-Canine KCTD5 Monoclonal Antibody

Canine KCTD5, or potassium channel tetramerization domain-containing 5, is a protein that has been identified as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity. It plays a significant role in the development of cancer and is involved in regulating the tumor immune microenvironment, showing correlations with the abundance of infiltrating immune cells and tumor-associated fibroblasts. KCTD5 is associated with various types of programmed cell death, including apoptosis, necroptosis, and autophagy, suggesting its involvement in the regulation of tumor cell apoptosis. Moreover, its expression is positively correlated with the sensitivity of many classical antitumor drugs, indicating its potential as a predictor of tumor response to chemotherapy.